Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atul Singhal

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Pediatrics|October 13, 2010
The effect of intrauterine growth on verbal IQ scores in childhood: a study of monozygotic twinsCaroline J Edmonds, Elizabeth B Isaacs, Tim J Cole, et al.
Pediatrics|April 18, 2012
Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolismBrenda A Kelly, Adam J Lewandowski, Stephanie A Worton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 StudyAlan Kivitz, Liliana Sedova, Melvin Churchill, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 2014
Elevated blood pressure in preterm-born offspring associates with a distinct antiangiogenic state and microvascular abnormalities in adult lifeAdam J Lewandowski, Esther F Davis, Grace Yu, et al.
Annals of the Rheumatic Diseases|March 19, 2018
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 studyPhilip Mease, Désirée van der Heijde, Robert Landewé, et al.
The American Journal of Clinical Nutrition|October 1, 2010
Nutrition in infancy and long-term risk of obesity: evidence from 2 randomized controlled trialsAtul Singhal, Kathy Kennedy, Julie Lanigan, et al.
RMD Open|July 31, 2021
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 studyPhilip J Mease, Robert Landewé, Proton Rahman, et al.
BMC Pediatrics|April 30, 2017
Early childhood obesity: a survey of knowledge and practices of physicians from the Middle East and North AfricaInge Gies, Bader AlSaleem, Beheshteh Olang, et al.
Nutrients|August 29, 2018
Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant FormulaYvan Vandenplas, Bernard Berger, Virgilio Paolo Carnielli, et al.
The Lancet. Rheumatology|January 31, 2024
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trialRoy Fleischmann, Alan Friedman, Edit Drescher, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Pediatrics|October 13, 2010
The effect of intrauterine growth on verbal IQ scores in childhood: a study of monozygotic twinsCaroline J Edmonds, Elizabeth B Isaacs, Tim J Cole, et al.
Pediatrics|April 18, 2012
Antenatal glucocorticoid exposure and long-term alterations in aortic function and glucose metabolismBrenda A Kelly, Adam J Lewandowski, Stephanie A Worton, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|September 19, 2024
Efficacy and Safety of Intravenous Secukinumab for the Treatment of Active Psoriatic Arthritis: Results From a Randomized, Placebo-Controlled Phase 3 StudyAlan Kivitz, Liliana Sedova, Melvin Churchill, et al.
Hypertension (Dallas, Tex. : 1979)|December 24, 2014
Elevated blood pressure in preterm-born offspring associates with a distinct antiangiogenic state and microvascular abnormalities in adult lifeAdam J Lewandowski, Esther F Davis, Grace Yu, et al.
Annals of the Rheumatic Diseases|March 19, 2018
Secukinumab improves active psoriatic arthritis symptoms and inhibits radiographic progression: primary results from the randomised, double-blind, phase III FUTURE 5 studyPhilip Mease, Désirée van der Heijde, Robert Landewé, et al.
The American Journal of Clinical Nutrition|October 1, 2010
Nutrition in infancy and long-term risk of obesity: evidence from 2 randomized controlled trialsAtul Singhal, Kathy Kennedy, Julie Lanigan, et al.
RMD Open|July 31, 2021
Secukinumab provides sustained improvement in signs and symptoms and low radiographic progression in patients with psoriatic arthritis: 2-year (end-of-study) results from the FUTURE 5 studyPhilip J Mease, Robert Landewé, Proton Rahman, et al.
BMC Pediatrics|April 30, 2017
Early childhood obesity: a survey of knowledge and practices of physicians from the Middle East and North AfricaInge Gies, Bader AlSaleem, Beheshteh Olang, et al.
Nutrients|August 29, 2018
Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant FormulaYvan Vandenplas, Bernard Berger, Virgilio Paolo Carnielli, et al.
The Lancet. Rheumatology|January 31, 2024
Safety and efficacy of elsubrutinib or upadacitinib alone or in combination (ABBV-599) in patients with rheumatoid arthritis and inadequate response or intolerance to biological therapies: a multicentre, double-blind, randomised, controlled, phase 2 trialRoy Fleischmann, Alan Friedman, Edit Drescher, et al.
Pageof 9